| Morgan Brittany Walkup, NP | |
|
1800 W University Blvd, Durant, OK 74701-3006 | |
| (580) 924-3080 | |
| (580) 920-8003 |
| Full Name | Morgan Brittany Walkup |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 1800 W University Blvd, Durant, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700453628 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 205371 (Oklahoma) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nes Oklahoma, Inc. | 1456264324 | 69 |
News Archive
Celecoxib combined with TNF inhibitors was associated with the greatest reduction in radiographic progression.
In a potential step forward for early pancreatic cancer diagnosis, a miniaturized brush was successfully tested as a possible technique for loosening cells from the walls of pancreatic cysts.
Allied Healthcare Group (ASX: AHZ) has announced an update on the progress of Coridon, its investment company founded by Professor Ian Frazer and working on developing the next generation of vaccines. Included in these activities, Cordon has entered into a license agreement with Nature Technology Corporation (NTC) and has contracted VGXI Inc. in the US for production of clinical material for the Phase I study scheduled to begin later this year.
Inhaled corticosteroids (ICS) are the first line of treatment to counter the inflammatory pathology in several conditions, including asthma and chronic obstructive pulmonary disease (COPD). Now, a new study published in the journal The Lancet Respiratory Medicine in September 2020 reports on the actual role of ICS in reducing COVID-19 mortality.
› Verified 3 days ago
| Entity Name | Nes Oklahoma, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528040722 PECOS PAC ID: 1456264324 Enrollment ID: O20040726000516 |
News Archive
Celecoxib combined with TNF inhibitors was associated with the greatest reduction in radiographic progression.
In a potential step forward for early pancreatic cancer diagnosis, a miniaturized brush was successfully tested as a possible technique for loosening cells from the walls of pancreatic cysts.
Allied Healthcare Group (ASX: AHZ) has announced an update on the progress of Coridon, its investment company founded by Professor Ian Frazer and working on developing the next generation of vaccines. Included in these activities, Cordon has entered into a license agreement with Nature Technology Corporation (NTC) and has contracted VGXI Inc. in the US for production of clinical material for the Phase I study scheduled to begin later this year.
Inhaled corticosteroids (ICS) are the first line of treatment to counter the inflammatory pathology in several conditions, including asthma and chronic obstructive pulmonary disease (COPD). Now, a new study published in the journal The Lancet Respiratory Medicine in September 2020 reports on the actual role of ICS in reducing COVID-19 mortality.
› Verified 3 days ago
| Entity Name | Oklahoma Emergency Physician Partners Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891039764 PECOS PAC ID: 0345493649 Enrollment ID: O20130118000115 |
News Archive
Celecoxib combined with TNF inhibitors was associated with the greatest reduction in radiographic progression.
In a potential step forward for early pancreatic cancer diagnosis, a miniaturized brush was successfully tested as a possible technique for loosening cells from the walls of pancreatic cysts.
Allied Healthcare Group (ASX: AHZ) has announced an update on the progress of Coridon, its investment company founded by Professor Ian Frazer and working on developing the next generation of vaccines. Included in these activities, Cordon has entered into a license agreement with Nature Technology Corporation (NTC) and has contracted VGXI Inc. in the US for production of clinical material for the Phase I study scheduled to begin later this year.
Inhaled corticosteroids (ICS) are the first line of treatment to counter the inflammatory pathology in several conditions, including asthma and chronic obstructive pulmonary disease (COPD). Now, a new study published in the journal The Lancet Respiratory Medicine in September 2020 reports on the actual role of ICS in reducing COVID-19 mortality.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Morgan Brittany Walkup, NP 200 Corporate Blvd, Lafayette, LA 70508-3870 Ph: (800) 893-9698 | Morgan Brittany Walkup, NP 1800 W University Blvd, Durant, OK 74701-3006 Ph: (580) 924-3080 |
News Archive
Celecoxib combined with TNF inhibitors was associated with the greatest reduction in radiographic progression.
In a potential step forward for early pancreatic cancer diagnosis, a miniaturized brush was successfully tested as a possible technique for loosening cells from the walls of pancreatic cysts.
Allied Healthcare Group (ASX: AHZ) has announced an update on the progress of Coridon, its investment company founded by Professor Ian Frazer and working on developing the next generation of vaccines. Included in these activities, Cordon has entered into a license agreement with Nature Technology Corporation (NTC) and has contracted VGXI Inc. in the US for production of clinical material for the Phase I study scheduled to begin later this year.
Inhaled corticosteroids (ICS) are the first line of treatment to counter the inflammatory pathology in several conditions, including asthma and chronic obstructive pulmonary disease (COPD). Now, a new study published in the journal The Lancet Respiratory Medicine in September 2020 reports on the actual role of ICS in reducing COVID-19 mortality.
› Verified 3 days ago
Darci Lynn Bowen, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1801 Chukka Hina, Durant, OK 74701 Phone: 580-920-2100 | |
Jodi Robinson, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1400 Bryan Dr, Suite 303, Durant, OK 74701 Phone: 580-931-2227 Fax: 580-931-2057 | |
Duncan Kovash, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1901 Chukka Hina, Durant, OK 74701 Phone: 580-920-2100 | |
Mrs. Jennifer Renee Nelson, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1708 Delivery Lane, Durant, OK 74701 Phone: 580-924-5622 Fax: 580-745-5060 | |
Mrs. Johnette L Routh, A.R.N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1400 Bryan Dr, #300, Durant, OK 74702 Phone: 580-924-1700 Fax: 580-924-1736 | |
Mrs. Jessica Laine Williams, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1400 Bryan Dr Ste 208, Durant, OK 74701 Phone: 580-920-9063 | |
Amanda Robertson, APRN, CNP, PMHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2701 W University Blvd, Durant, OK 74701 Phone: 580-740-4053 |